Information Provided By: 
Fly News Breaks for April 9, 2018
MRK, INCY, NLNK
Apr 9, 2018 | 05:15 EDT
Jefferies analyst Biren Amin late Friday downgraded NewLink Genetics (NLNK) to Hold from Buy and cut his price target for the shares to $4 from $17. The stock closed Friday down 43%, or $3.12, to $4.20. The analyst does not see a scenario in which the company's IDO inhibitor can avoid the same fate as Incyte and Merck's epacadostat plus Keytruda failed study.
News For NLNK;INCY;MRK From the Last 2 Days
There are no results for your query NLNK;INCY;MRK
